US Senator Tom Cotton has been frequently raising questions against the official story being propagated by the Chinese government parroted by mainstream media.

by upvoatz

The submitted clip is from February 16, 2020

Cotton discusses the Wuhan BSL-4 lab without outright accusing China of releasing a weaponized virus intentionally or by incompetence.

At a Senate Armed Services Committee hearing last month Senator Tom Cotten called for a travel ban to/from China and suggested the Coronavirus known as COVID-19 originated from the BSL-4 lab in Wuhan.

  • January 30, 2020: Senator Cotton Urges China Travel Ban in Wake of Coronavirus
    Jan 30, 2020


Most people are discussing passenger air travel, but aren’t thinking about air cargo or container shipping by sea.

consider how much of the worlds manufacturing capability has been outsourced to one country … China

  • electronics
  • packaging
  • medical supplies
  • pharmaceuticals
  • various goods including processed food

If the corona virus continues spreading you’re going to see a severe impact on global markets including shortages. That’s assuming the virus is contained to China.

Hundreds of pilots flying air cargo to/from China each day could be infected and spread the virus.

Packages and goods shipped from China on air cargo flights could contain active living corona virus which could infect anyone along a supply chain, including package handlers, customs, or the recipient.

Consider how much air freight ships from China each day to the United States, Canada, and Mexico, not counting goods sold through Ebay, Alibaba, or Amazon

Variants of corona virus can remain active for up to 28 days on surfaces at 39.2 ° F (4 °C)

www.ncbi.nlm.nih.gov/pmc/articles/PMC4659470/

We report here that pathogenic human coronavirus 229E remained infectious in a human lung cell culture model following at least 5 days of persistence on a range of common nonbiocidal surface materials, including polytetrafluoroethylene (Teflon; PTFE), polyvinyl chloride (PVC), ceramic tiles, glass, silicone rubber, and stainless steel. We have shown previously that noroviruses are destroyed on copper alloy surfaces. In this new study, human coronavirus 229E was rapidly inactivated on a range of copper alloys (within a few minutes for simulated fingertip contamination) and Cu/Zn brasses were very effective at lower copper concentration. Exposure to copper destroyed the viral genomes and irreversibly affected virus morphology, including disintegration of envelope and dispersal of surface spikes.

www.ncbi.nlm.nih.gov/pmc/articles/PMC2863430/

Effects of Air Temperature and Relative Humidity on Coronavirus Survival on Surfaces▿

Abstract
Assessment of the risks posed by severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) on surfaces requires data on survival of this virus on environmental surfaces and on how survival is affected by environmental variables, such as air temperature (AT) and relative humidity (RH). The use of surrogate viruses has the potential to overcome the challenges of working with SARS-CoV and to increase the available data on coronavirus survival on surfaces. Two potential surrogates were evaluated in this study; transmissible gastroenteritis virus (TGEV) and mouse hepatitis virus (MHV) were used to determine effects of AT and RH on the survival of coronaviruses on stainless steel. At 4°C, infectious virus persisted for as long as 28 days, and the lowest level of inactivation occurred at 20% RH. Inactivation was more rapid at 20°C than at 4°C at all humidity levels; the viruses persisted for 5 to 28 days, and the slowest inactivation occurred at low RH. Both viruses were inactivated more rapidly at 40°C than at 20°C. The relationship between inactivation and RH was not monotonic, and there was greater survival or a greater protective effect at low RH (20%) and high RH (80%) than at moderate RH (50%). There was also evidence of an interaction between AT and RH. The results show that when high numbers of viruses are deposited, TGEV and MHV may survive for days on surfaces at ATs and RHs typical of indoor environments. TGEV and MHV could serve as conservative surrogates for modeling exposure, the risk of transmission, and control measures for pathogenic enveloped viruses, such as SARS-CoV and influenza virus, on health care surfaces.

US Senator Tom Cotton – Coronavirus did not originate in the Wuhan food market – “A few miles away from that food market is China’s only Bio Safety Level 4 (BSL-4) super laboratory that researches human infectious diseases.”

 

 

www.cfr.org/blog/us-dependence-pharmaceutical-products-china

While the Department of Defense only purchases a small quantity of finished pharmaceuticals from China, about 80 percent of the active pharmaceutical ingredients (APIs) used to make drugs in the United States are said to come from China and other countries like India.

In order to address the growing security and safety concerns about Chinese-made pharmaceuticals, some suggest that the United States switch to India as an alternative API supplier. However, doing so would be no different from rearranging the deck chairs on the Titanic. It is true that many Indian pharmaceutical firms are leading API manufacturers but India depends on China for sourcing nearly three quarters of APIs in generic drug formulations. The disruption in the supply chain notwithstanding, switching to India for the supply of APIs would only make the drugs sold in the United States more expensive: APIs and chemical intermediates from China are 35 to 40 percent cheaper than Indian ones.

www.breitbart.com/asia/2020/02/13/coronavirus-outbreak-exposes-chinas-monopoly-on-u-s-drug-medical-supplies/

In testimony yesterday before the Senate Committee on Homeland Security and Governmental Affairs, Scott Gottlieb, a physician and the former Food and Drug Administration commissioner in the Trump administration, explained in detail the extent of the U.S. pharmaceutical industry’s dependence on China:

About 40 percent of generic drugs sold in the U.S. have only a single manufacturer. A significant supply chain disruption could cause shortages for some of many of these products.

Last year, manufacturing of intermediate or finished goods in China, as well as pharmaceutical source material, accounted for 95 percent of U.S. imports of ibuprofen, 91 percent of U.S. imports of hydrocortisone, 70 percent of U.S. imports of acetaminophen, 40 to 45 percent of U.S. imports of penicillin, and 40 percent of U.S. imports of heparin, according to the Commerce Department. In total, 80 percent of the U.S. supply of antibiotics are made in China.

While much of the fill finishing work (the actual formulation of finished drug capsules and tablets) is done outside China (and often in India) the starting and intermediate chemicals are often sourced in China. Moreover, the U.S. generic drug industry can no longer produce certain critical medicines such as penicillin and doxycycline without these chemical components.

According to a report from the US-China Economic and Security Review Commission, China’s chemical industry, which accounts for 40 percent of global chemical industry revenue, provides a large number of ingredients for drug products. It’s these source materials — where in many cases China is the exclusive source of the chemical ingredients used for the manufacture of a drug product — that create choke points in the global supply chain for critical medicines.

Moreover, when it comes to starting material for the manufacture of pharmaceutical ingredients, a lot of this production is centered in China’s Hubei Provence, the epicenter of coronavirus. Most drug makers have a one to three-months of inventory of drug ingredients on hand. But these supplies are already being drawn down. Among big [active pharmaceutical ingredient] makers in Wuhan are Wuhan Shiji Pharmaceutical, Chemwerth, Hubei Biocause, Wuhan Calmland Pharmaceuticals. [emphasis added]

www.breitbart.com/radio/2020/02/14/expert-china-has-global-chokehold-on-medicine-can-shut-down-our-pharmacies-hospitals-in-months/

Mansour noted how the coronavirus outbreak in China has exposed America’s dangerous dependence on Chinese production of pharmaceutical and medical supplies, including an estimated 97 percent of all antibiotics and 80 percent of the active pharmaceutical ingredients needed for domestic drug production.

Gibson said, “If China shuts the door on exports of medicines and the ingredients to make them, within a couple of months our pharmacies would be empty. Our healthcare system would cease to function. That’s how dependent we are.”